State Of Wyoming Uro Gen Pharma Ltd. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$8.84 - $22.64 $18,104 - $46,366	2,048 New	2,048 $28,000
Q2 2022 Aug 15, 2022	SELL	$5.12 - $8.74 $1,725 - $2,945	-337 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.92 - $9.73 $29 - $48	5 Added 1.51%	337 $3,000
Q4 2021 Feb 11, 2022	SELL	$9.03 - $19.13 $243 - $516	-27 Reduced 7.52%	332 $3,000
Q3 2021 Feb 11, 2022	BUY	$14.31 - $18.39 $4,192 - $5,388	293 Added 443.94%	359 $6,000
Q2 2021 Feb 11, 2022	BUY	$15.2 - $20.94 $1,003 - $1,382	66 New	66 $1,000

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $242M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.